To ensure cancer investigators have access to specialized technology and research services, the Hollings Cancer Center supports shared resources that are efficient, cost-effective and provide the latest industry standards for enhanced scientific productivity.
Provides advanced methodology, state-of-the-art facilities and expertise for both synthesis and analysis of bioactive lipids.
Offers comprehensive analytic flow cytometry and high-speed cell sorting services and the capacity to generate human cellular and tissue-based products for use in research.
Provides access to annotated human specimens and tissue microarrays as well as access to expert research pathology and imaging services.
Provides scientists access to genome-wide human and mouse libraries that together encode a total of almost 160,000 shRNA clones against over 41,000 genes.
Offers comprehensive Next Generation Sequencing applications utilizing Illumina HiSeq and Ion Torrent instrumentation.
Offers statistical support for the design of studies, analysis of data, quality control and manuscript preparation.
Serves as the central clinical research information repository for the Hollings Cancer Center and provides comprehensive services for the conduct of clinical trials.
If you publish a manuscript including research supported by a HCC Shared Resource, the following text is to be placed in the acknowledgement section: "Supported in part by the [Name] Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313)."